Abstract
PET/MRI is a rapidly evolving technique that takes advantage of its constituent modalities. MRI is unparalleled in evaluation bone marrow and soft tissues. PET assesses metabolic properties of tissues and continues to find new applications as novel radiopharmaceuticals are developed. Despite currently limited evidence for musculoskeletal application of PET/MRI, the combined strength of these constituent modalities underscores the importance of future work on this topic. In particular, PET/MRI is expected to play a major role in evaluating both primary musculoskeletal malignancies as well as bone and bone marrow metastases. It may also overcome some of the challenges that imaging faces while evaluating benign conditions like osteoarthritis, rheumatoid arthritis, and osteomyelitis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
